Skip to main content
. 2021 Nov 10;19(12):1746–1751. doi: 10.1111/ddg.14608

Table 2.

Clinical characteristics of Gianotti‐Crosti syndrome‐like reaction

n = 26 %
Morphology of GCLR

– papules

– plaques

– papulovesicles

– urticarial papules/plaques

– target‐like papules/plaques

26

12

4

2

2

100

46

15

8

8

Affected body areas

– extremities

 – upper extremities

  – accentuation over extensor surfaces/elbows

  – dorsal hands

  – palms

 – lower extremities

  – accentuation over extensor surfaces/knees

  – Achilles tendon

  – dorsal feet

  – soles

– face

– trunk

– buttocks

26

25

22

7

1

23

18

4

6

1

6

7

5

100

96

85

27

4

88

69

15

23

4

23

27

19

Severity of GCLR (PGA)

– 4

– 3

– 2

– 1

1

10

9

6

4

38

35

23

Symptoms associated with GCLR

– pruritus

– pain

– asymptomatic

20

1

5

77

4

19

Treatment for GCLR performed

– yes

– no

20

6

77

23

Total duration of GCLR (days; median, range)* 23.5 (10–150)
Resolution of MC after GCLR

– yes

– unknown

21

5

81

19

Time until resolution of MC after onset of GCLR (weeks; median, range) 9 (4–24)
*

Information available for 18 patients (69 %).